KAP regulates ROCK2 and Cdk2 in an RNA-activated glioblastoma invasion pathway

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Aberrant splicing of cyclin-dependent kinase-associated phosphatase (KAP) is linked to glioblastoma (GBM) invasion.
• The precise molecular mechanisms driving KAP-mediated GBM invasion remain largely unelucidated.

Purpose of the Study:

• To investigate the role of miR-26a in glioblastoma invasion.
• To elucidate the downstream signaling pathways regulated by KAP in GBM.

Main Methods:

• Quantitative real-time PCR and Western blotting to assess gene and protein expression.
• Cell invasion assays (e.g., Transwell assays) in PTEN-competent and PTEN-deficient glioblastoma cell lines.
• In vitro and in vivo experiments using Cdk2/Cdc2 inhibitors.

Main Results:

• miR-26a directly downregulates KAP expression in glioblastoma cells.
• Downregulation of KAP leads to increased ROCK2 activity and subsequent Rac1-mediated invasion.
• Reduced KAP expression activates Cdk2, promoting invasion via retinoblastoma phosphorylation and caldesmon inactivation.
• Glioblastoma invasion driven by this pathway is inhibited by Cdk2/Cdc2 inhibitors.

Conclusions:

• Two distinct RNA-mediated pathways involving miR-26a, KAP, ROCK2, and Cdk2 contribute to glioblastoma cell invasion.
• Targeting Cdk2/Cdc2 presents a potential therapeutic strategy against glioblastoma invasion.